NAD+ and Healthy Aging: What It Is and What the Research Shows

Every cell in your body relies on a small molecule called NAD+ (short for nicotinamide adenine dinucleotide). Scientists first found it in 1906 while studying how yeast turns sugar into alcohol (Harden & Young, 1906). Since then, researchers have learned that NAD+ is just as important in people as it is in yeast.

Here is a plain-language look at what NAD+ does, how it changes as we get older, and what studies have and have not found so far.

What Does NAD+ Do?

NAD+ is a helper molecule. Enzymes, the proteins that carry out chemical reactions in your cells, need it to do their jobs. NAD+ has two main roles (Covarrubias et al., 2021).

1. Helping turn food into energy

When your cells break down food, they release electrons, tiny charged particles that hold energy. NAD+ picks up these electrons and carries them to the mitochondria, the parts of the cell that turn that energy into a form the body can use. While NAD+ is carrying electrons, it is called NADH. Once it drops them off, it becomes NAD+ again and is ready for the next load. This back-and-forth happens constantly in every cell.

2. Helping keep cells in good working order

Some enzymes use up NAD+ as they work:

  • Sirtuins help cells adjust how they use energy and which genes are switched on or off. They also play a part in the body's daily sleep-wake rhythm.

  • PARPs respond when DNA gets damaged and help organize the repair.

  • CD38 is an enzyme found mainly on immune cells. It breaks NAD+ down.

Because these enzymes use NAD+ up, cells need a steady supply to keep them going.

Does NAD+ Change as We Get Older?

Studies suggest it does. In one study of skin samples from 49 people, ranging from newborns to age 77, older people had lower NAD+ levels than younger people, in both men and women (Massudi et al., 2012). Studies that measure NAD+ in blood have been less consistent, and levels differ from one part of the body to another.

Scientists have two leading explanations for the drop:

  • More demand. Everyday wear and tear on DNA adds up over time. PARP enzymes use more NAD+ as they respond to it.

  • More breakdown. In mice, CD38 levels rise with age and account for much of the drop in NAD+ in their tissues (Camacho-Pereira et al., 2016).

One important point: lower NAD+ shows up alongside many other changes that come with age. Scientists do not yet know whether lower NAD+ causes those changes in people or simply happens at the same time.

What Have Animal Studies Found?

Much of the early research on NAD+ was done in mice. In one study, mice given NMN (a building block the body uses to make NAD+) for 12 months showed smaller age-related declines in energy use and physical activity than mice that did not get it (Mills et al., 2016).

Studies looking at lifespan in animals have had mixed results. A large study run through the National Institute on Aging, at three separate labs, found that NR (another NAD+ building block) did not help mice live longer (Harrison et al., 2021). No study has tested whether NAD+ building blocks affect how long people live. It is also worth remembering that results in mice often do not carry over to people.

What Have Human Studies Found?

Research in people is newer, and most studies so far have been small and short. The clearest finding is that taking NMN or NR raises NAD+ levels in the blood (Martens et al., 2018; Igarashi et al., 2022). Beyond that, results are early. Several of these studies compared NMN with a placebo, a look-alike capsule with no active ingredient, which helps show whether changes come from NMN itself.

  • Older men. Healthy men aged 65 and older took 250 mg of NMN or a placebo daily for 12 weeks. Walking speed and grip strength in the left hand improved more with NMN on some tests. Right-hand grip, a sit-to-stand test, and muscle size did not change. The researchers said larger studies are needed to confirm the results (Igarashi et al., 2022).

  • Runners. 48 recreational runners who were already training regularly took 300, 600, or 1,200 mg of NMN or a placebo daily for 6 weeks. The NMN groups used oxygen more efficiently during exercise, and the effect was larger at higher doses. Their maximum oxygen capacity (VO2max) did not change (Liao et al., 2021).

  • NR studies. Studies measuring other outcomes with NR, such as how the body handles energy from food or how muscles perform, have not found consistent changes (Dollerup et al., 2018; Elhassan et al., 2019).

More studies are underway, and larger, longer trials will give a clearer picture.

Where Does the Body Get NAD+?

Your body builds NAD+ from raw materials called precursors. Most of them are forms of vitamin B3. The body has three main routes:

  • The recycling route. Nicotinamide (also called niacinamide), NMN, and NR all feed a recycling system known as the salvage pathway. Each time NAD+ is used up, the leftover nicotinamide can be turned back into NAD+. Most of the body's NAD+ is made this way.

  • The niacin route. Niacin, another form of vitamin B3, is turned into NAD+ through a separate set of steps.

  • The tryptophan route. The body can also make NAD+ from tryptophan, an amino acid found in protein foods, though this route is longer.

Other Compounds Researchers Are Studying

Scientists are also looking at plant compounds that might affect the enzymes that use up or break down NAD+. This research is at an early stage, and most of it has been done in cells in a lab or in animals.

Compounds that may slow NAD+ breakdown

  • Quercetin is found in many fruits and vegetables, such as apples and onions. In lab and mouse studies, it blocked CD38 (Escande et al., 2013).

  • Apigenin is found in chamomile, parsley, and celery. In lab and mouse studies, it blocked CD38 and raised NAD+ levels in tissues (Escande et al., 2013).

  • Luteolin is related to quercetin. It blocked CD38 in lab studies (Kellenberger et al., 2011).

These compounds have not yet been tested in people to see whether they block CD38 at supplement doses.

Compounds studied for effects on sirtuins

Trans-resveratrol, the form of resveratrol found in grapes, and pterostilbene, a related compound found in blueberries, have been studied for their effects on sirtuins, mostly in lab models. Scientists still disagree about whether resveratrol acts on sirtuins directly (Hubbard et al., 2013; Pacholec et al., 2010). These compounds do not add to the body's NAD+; sirtuins use NAD+ as they work.

The Bottom Line

  • NAD+ is a helper molecule every cell needs to make energy and to keep enzymes involved in metabolism and DNA repair running.

  • NAD+ levels tend to be lower in older adults. Scientists think this is partly because the body uses more of it and breaks down more of it with age.

  • Taking NMN or NR raises NAD+ in the blood. Early studies on other effects in people are small, short, and mixed.

  • Research on plant compounds that affect NAD+-related enzymes has mostly been done in labs and animals so far.

Explore GetHealthy Stores and Script to start recommending ProHealth Longevity online.

Explore GetHealthy Stores
Learn more about GetHealthy Script


*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. This article is for educational purposes only and is not medical advice.

References

  1. Camacho-Pereira, J., Tarragó, M. G., Chini, C. C. S., Nin, V., Escande, C., Warner, G. M., Puranik, A. S., Schoon, R. A., Reid, J. M., Galina, A., & Chini, E. N. (2016). CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metabolism, 23(6), 1127–1139.
  2. Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 22(2), 119–141.
  3. Dollerup, O. L., Christensen, B., Svart, M., Schmidt, M. S., Sulek, K., Ringgaard, S., Stødkilde-Jørgensen, H., Møller, N., Brenner, C., Treebak, J. T., & Jessen, N. (2018). A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: Safety, insulin-sensitivity, and lipid-mobilizing effects. American Journal of Clinical Nutrition, 108(2), 343–353.
  4. Elhassan, Y. S., Kluckova, K., Fletcher, R. S., Schmidt, M. S., Garten, A., Doig, C. L., Cartwright, D. M., Oakey, L., Burley, C. V., Jenkinson, N., Wilson, M., Lucas, S. J. E., Akerman, I., Seabright, A., Lai, Y.-C., Tennant, D. A., Nightingale, P., Wallis, G. A., Manolopoulos, K. N., ... Lavery, G. G. (2019). Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Reports, 28(7), 1717–1728.
  5. Escande, C., Nin, V., Price, N. L., Capellini, V., Gomes, A. P., Barbosa, M. T., O'Neil, L., White, T. A., Sinclair, D. A., & Chini, E. N. (2013). Flavonoid apigenin is an inhibitor of the NAD+ase CD38: Implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes, 62(4), 1084–1093.
  6. Harden, A., & Young, W. J. (1906). The alcoholic ferment of yeast-juice. Proceedings of the Royal Society of London, Series B, 77(519), 405–420.
  7. Harrison, D. E., Strong, R., Reifsnyder, P., Kumar, N., Fernandez, E., Flurkey, K., Javors, M. A., Lopez-Cruzan, M., Macchiarini, F., Nelson, J. F., Markewych, A., Bitto, A., Sindler, A. L., Cortopassi, G., Kavanagh, K., Leng, L., Bucala, R., Rosenthal, N., Salmon, A., ... Miller, R. A. (2021). 17-a-estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex. Aging Cell, 20(5), e13328.
  8. Hubbard, B. P., Gomes, A. P., Dai, H., Li, J., Case, A. W., Considine, T., Riera, T. V., Lee, J. E., E, S. Y., Lamming, D. W., Pentelute, B. L., Schuman, E. R., Stevens, L. A., Ling, A. J. Y., Armour, S. M., Michan, S., Zhao, H., Jiang, Y., Sweitzer, S. M., ... Sinclair, D. A. (2013). Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science, 339(6124), 1216–1219.
  9. Igarashi, M., Nakagawa-Nagahama, Y., Miura, M., Kashiwabara, K., Yaku, K., Sawada, M., Sekine, R., Fukamizu, Y., Sato, T., Sakurai, T., Sato, J., Ino, K., Kubota, N., Nakagawa, T., Kadowaki, T., & Yamauchi, T. (2022). Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Aging, 8, 5.
  10. Kellenberger, E., Kuhn, I., Schuber, F., & Muller-Steffner, H. (2011). Flavonoids as inhibitors of human CD38. Bioorganic & Medicinal Chemistry Letters, 21(13), 3939–3942.
  11. Liao, B., Zhao, Y., Wang, D., Zhang, X., Hao, X., & Hu, M. (2021). Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: A randomized, double-blind study. Journal of the International Society of Sports Nutrition, 18, 54.
  12. Martens, C. R., Denman, B. A., Mazzo, M. R., Armstrong, M. L., Reisdorph, N., McQueen, M. B., Chonchol, M., & Seals, D. R. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications, 9, 1286.
  13. Massudi, H., Grant, R., Braidy, N., Guest, J., Farnsworth, B., & Guillemin, G. J. (2012). Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One, 7(7), e42357.
  14. Mills, K. F., Yoshida, S., Stein, L. R., Grozio, A., Kubota, S., Sasaki, Y., Redpath, P., Migaud, M. E., Apte, R. S., Uchida, K., Yoshino, J., & Imai, S. (2016). Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metabolism, 24(6), 795–806.
  15. Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., Qiu, X., Stockman, B., Thanabal, V., Varghese, A., Ward, J., Withka, J., & Ahn, K. (2010). SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. Journal of Biological Chemistry, 285(11), 8340–8351.

Next
Next

How to Build an Email List for Your Health and Wellness Practice